Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Quick Stats
Feb 02, 202664.2
AI Score
BUY1.23
Volume Ratio
Feb 11, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
RPRX Stock Summary
Last updated Feb 02, 2026
RPRX is currently trading at $42.36, positioned above its 200-day moving average of $36.55, indicating a long-term uptrend. The stock has a 52-week range of $29.66 to $42.375.
Technical Analysis: The 50-day moving average stands at $39.55, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 70.443, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.326, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RPRX at 64.2/100 with a BUY recommendation.
RPRX (Royalty Pharma plc Class A Ordinary Shares) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 70.443 |
| CMF (20) | 0.326 |
| ROC (10) | 7.105 |
| ADX (14) | 15.318 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.564 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -0.427 |
| MFI (14) | 67.349 |
RPRX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RPRX Price vs Max Options Open Interest
RPRX Max Change In Options Open Interest
RPRX Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RPRX Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RPRX Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RPRX Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Royalty Pharma plc Class A Ordinary Shares is above both 50 Day and 200 Day SMA which is considered Bullish.
RPRX Moving Averages Analysis
Royalty Pharma plc Class A Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
Royalty Pharma plc Class A Ordinary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
RPRX (Royalty Pharma plc Class A Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 40.56 |
| 20 | 40.39 |
| 30 | 39.9 |
| 50 | 39.55 |
| 100 | 38.23 |
| 200 | 36.55 |
RPRX Fundamental Analysis
| P/E (Forward) | 12.1065 |
| P/E (Trailing) | 23.4157 |
| Market Cap ($) | 24.3 billion |
| Earnings/Share ($) | 1.78 |
| Net Proft Margin (%) | 0.3255 |
| Dividend/Share ($) | 0.87 |
| EPS Estimate Current Year ($) | 4.6382 |
| EPS Estimate Next Year ($) | 5.1165 |
| WallStreet Target Price ($) | 48.0956 |
| Most Recent Quarter |